medical illustration of a human liver

Ever wondered how chronic liver diseases impact medication effectiveness?

The study „Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactions“ conducted by Dr. Sara Armani and Thomas Forst, Prof. Dr. (in collaboration with our partners from around the world) delves into this crucial topic.

Their research shows that liver diseases can significantly impact how medications work in the body. Conditions such as type 2 diabetes, steatotic liver disease, and cirrhosis can significantly alter drug metabolism and transport proteins, highlighting the importance of tailored medication management for patients with chronic liver diseases.

Read the study here: